PharMetrics’ Jim Carroll, director of Product Management and Taryn Foniri, product marketing manager, describe how anonymized patient-level data (APLD) allows pharma companies to identify new opportunities, allocate resources more efficiently and drive more profitable growth in today’s complex environment. Click here to read the entire thought leadership piece.